THE APEX TIMES
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
Popular tech reviewer Marques Brownlee, known online as MKBHD, said he would honor a Tesla Cybercab bet tied to 2024. In a post shared on the platform X, Brownlee said he has placed an order for the vehicle, indicating that he intends to follow through on the terms of the challenge.
Brownlee’s message prompted a short reply from Tesla CEO Elon Musk. Musk responded “fair enough,” and added that he would accept delivery, according to the social-media exchange reported by Yahoo Finance via Stocktwits.
The exchange centers on a public, time-stamped commitment that each side had discussed in connection with Cybercab. While Brownlee’s statement indicates he is moving from discussion to action by placing an order, neither Brownlee nor Musk, in the reported remarks, provided additional details about the order terms or timing.
Tesla did not issue a separate statement in the reported account, and the social posts themselves did not lay out operational specifics such as delivery schedules, configuration options, or any refund or cancellation language tied to the bet.
For Tesla, the episode is notable less for new corporate policy than for how quickly a high-profile consumer bet and a celebrity creator’s purchase decision can become part of the company’s broader public narrative. Cybercab, frequently discussed as a next step in Tesla’s push toward vehicle automation and ride-hailing-like use cases, has remained a focal point for investor and consumer attention.
The back-and-forth also highlights a recurring dynamic around Tesla’s upcoming products, where public commitments and creator-driven media coverage can amplify expectations faster than traditional corporate announcements. In this case, the reported sequence suggests a direct, personal follow-through, with Musk acknowledging Brownlee’s move and indicating he would accept delivery as well.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
A recent analyst upgrade focus shifted toward profitability drivers inside Medicare Advantage and the operational momentum of Optum Health, as well as what the bank characterizes as disciplined pricing.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...